The DOI matches its Crossref record; 67 of the 67 references it cites were found in a registry or an index.
Signatures of mutational processes in human cancer
Open accessAbstract
All cancers are caused by somatic mutations; however, understanding of the biological processes generating these mutations is limited. The catalogue of somatic mutations from a cancer genome bears the signatures of the mutational processes that have been operative. Here we analysed 4,938,362 mutations from 7,042 cancers and extracted more than 20 distinct mutational signatures. Some are present in many cancer types, notably a signature attributed to the APOBEC family of cytidine deaminases, whereas others are confined to a single cancer class. Certain signatures are associated with age of the patient at cancer diagnosis, known mutagenic exposures or defects in DNA maintenance, but many are of cryptic origin. In addition to these genome-wide mutational signatures, hypermutation localized to small genomic regions, 'kataegis', is found in many cancer types. The results reveal the diversity of mutational processes underlying the development of cancer, with potential implications for understanding of cancer aetiology, prevention and therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The use of TAA-derived epitopes has the advantage of allowing development of an off-the-shelf product for a tumour indication with low mutational burden such as GBM, where patients’ tumours express only few tumour-specific antigens [38].”
From Preclinical development of an mRNA-based multiepitope immunotherapeutic for glioblastoma (2025) · cites this paper as [38]
Experimental — accuracy not yet measuredIn the citing paper
“In MM, SBS9, associated with mutations introduced by polymerase η repair of activation-induced deaminase (AID) activity26,31,32, was strongly linked with Q61H”
From The origins and genetic interactions of KRAS mutations are allele- and tissue-specific (2021) · cites this paper as [26]
In the citing paper
“Five substitution and five rearrangement signatures [8, 9] were identified”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [8]
In the citing paper
“a high SNV burden associated with APOBEC substitution signature [8]”
From Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) · cites this paper as [8]
In the citing paper
“It has also been noted that the 'pol h mutational signature' (Signature 9; http://cancer.sanger.ac.uk/cosmic/sig natures) occurs in chronic lymphocytic leukemia and malignant Bcell lymphoma genomes 6,26,27 .”
From DNA polymerase η mutational signatures are found in a variety of different types of cancer (2018) · cites this paper as [6]
In the citing paper
“Several distinct mutational signatures sculpt the genome of NSCLC – including signatures of tobacco exposure and APOBEC-mediated cytidine deamination57.”
From Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy (2019) · cites this paper as [57]
In the citing paper
“Melanoma somatic mutations consist almost entirely of C → T transitions, 28% of which are TCC → T mutations (19,31).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [19]
In the citing paper
“Excess C → T transitions are characteristic of several different mutagenic processes including UV damage and cytosine deamination (19).”
From Evidence for recent, population-specific evolution of the human mutation rate (2015) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Comprehensive molecular characterization of human colon and rectal cancer
The Cancer Genome Atlas Network (2012) · Nature · doi:10.1038/nature11252 · Cited by 8,499
An integrated map of genetic variation from 1,092 human genomes
The 1000 Genomes Project Consortium (2012) · Nature · doi:10.1038/nature11632 · Cited by 7,711
dbSNP: the NCBI database of genetic variation
Sherry, S. T. (2001) · Nucleic Acids Research · doi:10.1093/nar/29.1.308 · Cited by 7,502
Integrated genomic characterization of endometrial carcinoma
The Cancer Genome Atlas Research Network, & Levine, D. A. (2013) · Nature · doi:10.1038/nature12113 · Cited by 5,784
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Lawrence, M. S., Stojanov, P., Polak, P., Kryukov, G. V., Cibulskis, K., Sivachenko, A., Carter, S. L., Stewart, C., Mermel, C. H., Roberts, S. A., et al. (2013) · Nature · doi:10.1038/nature12213 · Cited by 5,461
Self-citationStratton, M. R., Campbell, P. J., & Futreal, P. A. (2009) · Nature · doi:10.1038/nature07943 · Cited by 3,625
Self-citationSomatic mutations affect key pathways in lung adenocarcinoma
Ding, L., Getz, G., Wheeler, D. A., Mardis, E. R., McLellan, M. D., Cibulskis, K., Sougnez, C., Greulich, H., Muzny, D. M., Morgan, M. B., et al. (2008) · Nature · doi:10.1038/nature07423 · Cited by 2,681
Self-citationA landscape of driver mutations in melanoma
Hodis, E., Watson, I. R., Kryukov, G. V., Arold, S. T., Imielinski, M., Theurillat, J.-P., Nickerson, E., Auclair, D., Li, L., Place, C., et al. (2012) · Cell · doi:10.1016/j.cell.2012.06.024 · Cited by 2,610
Self-citationThe Mutational Landscape of Head and Neck Squamous Cell Carcinoma
Stransky, N., Egloff, A. M., Tward, A. D., Kostic, A. D., Cibulskis, K., Sivachenko, A., Kryukov, G. V., Lawrence, M. S., Sougnez, C. L., McKenna, A., et al. (2011) · Science · doi:10.1126/science.1208130 · Cited by 2,541
Self-citationThe mutational landscape of lethal castration-resistant prostate cancer
Grasso, C. S., Wu, Y.-M., Robinson, D. R., Cao, X., Dhanasekaran, S. M., Khan, A. P., Quist, M. J., Jing, X., Lonigro, R. J., Brenner, J. C., et al. (2012) · Nature · doi:10.1038/nature11125 · Cited by 2,517
Flagged first, then by citations
Cited by
Sorted by citations
Items 801–900 of 1,100
Tosolini, M., Pont, F., Poupot, M., Vergez, F., Nicolau-Travers, M.-L., Vermijlen, D., Sarry, J., Dieli, F., & Fournié, J. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1284723 · Cited by 197
Kennedy, A. L., Myers, K. C., Bowman, J. R., Gibson, C. J., Camarda, N. D., Furutani, E., Muscato, G. M., Klein, R. H., Ballotti, K., Liu, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21588-4 · Cited by 197
Hendry, S. A., Farnsworth, R. H., Solomon, B., Achen, M. G., Stacker, S. A., & Fox, S. B. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00621 · Cited by 188
Telomerase reverse transcriptase promoter mutations in primary cutaneous melanoma
Heidenreich, B., Nagore, E., Rachakonda, P. S., García‐Casado, Z., Requena, C., Traves, V., Becker, J. C., Soufir, N., Hemminki, K., & Kumar, R. (2014) · Nature Communications · doi:10.1038/ncomms4401 · Cited by 188
Enwere, E. K., Kornaga, E. N., Dean, M. L., Koulis, T. A., Phan, T., Kalantarian, M., Köbel, M., Ghatage, P., Magliocco, A. M., Lees‐Miller, S. P., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.221 · Cited by 190
Burugu, S., Gao, D., Leung, S. C. Y., Chia, S., & Nielsen, T. O. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx557 · Cited by 193
Update on genetic predisposition to colorectal cancer and polyposis
Valle, L., de Voer, R. M., Goldberg, Y., Sjursen, W., Försti, A., Ruíz-Ponte, C., Caldés, T., Garré, P., Olsen, M. F., Nordling, M., et al. (2019) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2019.03.001 · Cited by 197
Zhong, W., Myers, J. S., Wang, F., Wang, K., Lucas, J., Rosfjord, E. C., Lucas, J., Hooper, A. T., Yang, S., Lemon, L., et al. (2020) · BMC Genomics · doi:10.1186/s12864-019-6344-3 · Cited by 194
Immunogenomic Landscape of Hematological Malignancies
Dufva, O., Pölönen, P., Brück, O. E., Keränen, M. A. I., Klievink, J., Mehtonen, J., Huuhtanen, J., Kumar, A., Malani, D., Siitonen, S. M., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.06.002 · Cited by 194
Clusters of Multiple Mutations: Incidence and Molecular Mechanisms
Chan, K., & Gordenin, D. A. (2015) · Annual Review of Genetics · doi:10.1146/annurev-genet-112414-054714 · Cited by 191
Lung Cancer in the Era of Precision Medicine
Politi, K. A., & Herbst, R. S. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2748 · Cited by 190
APOBEC3A Functions as a Restriction Factor of Human Papillomavirus
Warren, C. J., Xu, T., Guo, K., Griffin, L., Westrich, J. A., Lee, D., Lambert, P. F., Santiago, M. L., & Pyeon, D. (2014) · Journal of Virology · doi:10.1128/jvi.02383-14 · Cited by 193
Causal Inference in Cancer Epidemiology: What Is the Role of Mendelian Randomization?
Yarmolinsky, J., Wade, K. H., Richmond, R. C., Langdon, R., Bull, C. J., Tilling, K. M., Relton, C. L., Lewis, S. J., Smith, G. D., & Martin, R. M. (2018) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-17-1177 · Cited by 189
Gettinger, S. N., Choi, J., Mani, N. L., Sanmamed, M. F., Datar, I. J., Sowell, R., Du, V. Y., Kaftan, E. J., Goldberg, S. B., Dong, W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-05032-8 · Cited by 188
Integrated genomic profiling expands clinical options for patients with cancer
Beaubier, N. T., Bontrager, M., Huether, R., Igartua, C., Lau, D., Tell, R. W., Bobe, A. M., Bush, S. J., Chang, A. L., Hoskinson, D. C., et al. (2019) · Nature Biotechnology · doi:10.1038/s41587-019-0259-z · Cited by 188
Immunobiology of high-grade serous ovarian cancer: lessons for clinical translation
Kandalaft, L. E., Laniti, D. D., & Coukos, G. (2022) · Nature reviews. Cancer · doi:10.1038/s41568-022-00503-z · Cited by 190
Fizazi, K., Drake, C. G., Beer, T. M., Kwon, E. D., Scher, H. I., Gerritsen, W. R., Bossi, A., den Eertwegh, A. J. M. V., Krainer, M., Houede, N., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.07.032 · Cited by 185
Middlebrooks, C. D., Banday, A. R., Matsuda, K., Udquim, K.-I., Onabajo, O. O., Paquin, A., Figueroa, J. D., Zhu, B., Koutros, S., Kubo, M., et al. (2016) · Nature Genetics · doi:10.1038/ng.3670 · Cited by 185
Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
de Coaña, Y. P., Choudhury, A., & Kiessling, R. W. (2015) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2015.05.005 · Cited by 187
Genomic landscape of carcinogen-induced and genetically induced mouse skin squamous cell carcinoma
Nassar, D., Latil, M., Boeckx, B., Lambrechts, D., & Blanpain, C. (2015) · Nature Medicine · doi:10.1038/nm.3878 · Cited by 188
Transmissible Dog Cancer Genome Reveals the Origin and History of an Ancient Cell Lineage
Murchison, E. P., Wedge, D. C., Alexandrov, L. B., Fu, B., Martincorena, I., Ning, Z., Tubío, J. M. C., Werner, E., Allen, J., Nardi, A. B. D., et al. (2014) · Science · doi:10.1126/science.1247167 · Cited by 193
Self-citationZheng, H., Dai, W., Cheung, A. K. L., Ko, J. M. Y., Kan, R., Wong, B. W. Y., Leong, M. M., Deng, M., Kwok, T. C. T., Chan, J. Y. W., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1607606113 · Cited by 187
Tı́már, J., & Ladányi, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105384 · Cited by 199
Expanding the computational toolbox for mining cancer genomes
Ding, L., Wendl, M. C., McMichael, J. F., & Raphael, B. J. (2014) · Nature Reviews Genetics · doi:10.1038/nrg3767 · Cited by 188
Pancreatic Cancer Stroma: Friend or Foe?
Gore, J., & Korc, M. (2014) · Cancer Cell · doi:10.1016/j.ccr.2014.05.026 · Cited by 184
Oberg, J. A., Bender, J. G., Sulis, M. L., Pendrick, D., Sireci, A. N., Hsiao, S. J., Turk, A. T., Cruz, F. S. D., Hibshoosh, H. H., Remotti, H. E., et al. (2016) · Genome Medicine · doi:10.1186/s13073-016-0389-6 · Cited by 188
Proportion of Never-Smoker Non–Small Cell Lung Cancer Patients at Three Diverse Institutions
Pelosof, L. C., Ahn, C. W., Gao, A., Horn, L., Madrigales, A., Cox, J., McGavic, D., Minna, J. D., Gazdar, A. F., & Schiller, J. H. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw295 · Cited by 184
Biomarkers for Immune Checkpoint Inhibitor-Mediated Tumor Response and Adverse Events
Nakamura, Y. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00119 · Cited by 185
Whole-genome sequencing of acral melanoma reveals genomic complexity and diversity
Newell, F., Wilmott, J. S., Johansson, P. A., Nones, K., Addala, V., Mukhopadhyay, P., Broit, N., Amato, C. M., Gulick, R. J. V., Kazakoff, S. H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18988-3 · Cited by 185
Self-citationThe Epigenetic Hallmarks of Cancer
Esteller, M., Dawson, M. A., Kadoch, C., Rassool, F. V., Jones, P. A., & Baylin, S. B. (2024) · Cancer Discovery · doi:10.1158/2159-8290.cd-24-0296 · Cited by 202
A practical guide for mutational signature analysis in hematological malignancies
Maura, F., Degasperi, A., Nadeu, F., Leongamornlert, D., Davies, H., Moore, L., Royo, R., Ziccheddu, B., Puente, X. S., Avet-Loiseau, H., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-11037-8 · Cited by 184
Self-citationA body map of somatic mutagenesis in morphologically normal human tissues
Li, R., Di, L., Li, J., Fan, W., Liu, Y., Guo, W., Liu, W., Liu, L., Li, Q., Chen, L., et al. (2021) · Nature · doi:10.1038/s41586-021-03836-1 · Cited by 183
Ogiwara, H., Sasaki, M., Mitachi, T., Oike, T., Higuchi, S., Tominaga, Y., & Kohno, T. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0754 · Cited by 185
Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma
Yachida, S., Wood, L. D., Suzuki, M., Takai, E., Totoki, Y., Kato, M., Luchini, C., Arai, Y., Nakamura, H. K., Hama, N., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2015.12.012 · Cited by 183
Self-citationClinical Significance of PD-L1 Protein Expression in Surgically Resected Primary Lung Adenocarcinoma
Takada, K., Okamoto, T., Shoji, F., Shimokawa, M., Akamine, T., Takamori, S., Katsura, M., Suzuki, Y., Fujishita, T., Toyokawa, G., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.06.006 · Cited by 183
Cancer systems biology: embracing complexity to develop better anticancer therapeutic strategies
Du, W., & Elemento, O. (2014) · Oncogene · doi:10.1038/onc.2014.291 · Cited by 185
Modeling cancer metabolism on a genome scale
Yizhak, K., Chaneton, B., Gottlieb, E., & Ruppin, E. (2015) · Molecular Systems Biology · doi:10.15252/msb.20145307 · Cited by 187
Acute myeloid leukaemia: a paradigm for the clonal evolution of cancer?
Grove, C. S., & Vassiliou, G. S. (2014) · Disease Models & Mechanisms · doi:10.1242/dmm.015974 · Cited by 202
Mutations, kataegis and translocations in B cells: understanding AID promiscuous activity
Casellas, R. C., Basu, U., Yewdell, W. T., Chaudhuri, J., Robbiani, D. F., & Noia, J. M. D. (2016) · Nature reviews. Immunology · doi:10.1038/nri.2016.2 · Cited by 182
The GSK3 Signaling Axis Regulates Adaptive Glutamine Metabolism in Lung Squamous Cell Carcinoma
Momcilovic, M., Bailey, S. T., Lee, J. T., Fishbein, M. C., Braas, D., Go, J. L., Graeber, T. G., Parlati, F., Demo, S. D., Li, R., et al. (2018) · Cancer Cell · doi:10.1016/j.ccell.2018.04.002 · Cited by 187
Sipuleucel-T for the Treatment of Prostate Cancer: Novel Insights and Future Directions
Handy, C. E., & Antonarakis, E. S. (2017) · Future Oncology · doi:10.2217/fon-2017-0531 · Cited by 186
HPV16 drives cancer immune escape via NLRX1-mediated degradation of STING
Luo, X., Donnelly, C. R., Gong, W., Heath, B. R., Hao, Y., Donnelly, L. A., Moghbeli, T., Tan, Y. S., Lin, X., Bellile, E. L., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci129497 · Cited by 182
Meier, B., Cooke, S. L., Weiss, J., Bailly, A., Alexandrov, L. B., Marshall, J., Raine, K. M., Maddison, M., Anderson, E. L., Stratton, M. R., et al. (2014) · Genome Research · doi:10.1101/gr.175547.114 · Cited by 187
Self-citationFrey, B., Rückert, M., Deloch, L., Rühle, P. F., Derer, A., Fietkau, R., & Gaipl, U. S. (2017) · Immunological Reviews · doi:10.1111/imr.12572 · Cited by 189
Adoptive Cell Therapy Targeting Neoantigens: A Frontier for Cancer Research
Wang, Z., & Cao, Y. J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00176 · Cited by 188
Lung Adenocarcinoma Tumor Origin: A Guide for Personalized Medicine
Seguin, L., Durandy, M., & Féral, C. C. (2022) · Cancers · doi:10.3390/cancers14071759 · Cited by 188
Brown, D. N., Smeets, D., Székely, B., Larsimont, D., Szász, A. M., Adnet, P.-Y., Rothé, F., Rouas, G., Nagy, Z., Faragó, Z., et al. (2017) · Nature Communications · doi:10.1038/ncomms14944 · Cited by 183
Self-citationCurrent issues and perspectives in PD-1 blockade cancer immunotherapy
Chamoto, K., Hatae, R., & Honjo, T. (2020) · International Journal of Clinical Oncology · doi:10.1007/s10147-019-01588-7 · Cited by 188
Widespread Transcriptional Scanning in the Testis Modulates Gene Evolution Rates
Xia, B., Yan, Y., Baron, M., Wagner, F., Barkley, D., Chiodin, M., Kim, S. Y., Keefe, D. L., Alukal, J. P., Boeke, J. D., et al. (2020) · Cell · doi:10.1016/j.cell.2019.12.015 · Cited by 190
Majzner, R. G., Simon, J. S., Grosso, J. F., Martinez, D., Pawel, B. R., Santi, M., Merchant, M. S., Geoerger, B., Hezam, I., Marty, V., et al. (2017) · Cancer · doi:10.1002/cncr.30724 · Cited by 179
Aging-Induced Stem Cell Mutations as Drivers for Disease and Cancer
Adams, P. D., Jasper, H., & Rudolph, K. L. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.05.002 · Cited by 182
A comprehensive survey of the mutagenic impact of common cancer cytotoxics
Szikriszt, B., Póti, Á., Pipek, O., Krzystanek, M., Kanu, N., Molnár, J., Ribli, D., Szeltner, Z., Tusnády, G., Csabai, I., et al. (2016) · Genome biology · doi:10.1186/s13059-016-0963-7 · Cited by 188
Homologous Recombination Deficiency and Platinum-Based Therapy Outcomes in Advanced Breast Cancer
Stutheit-Zhao, E. Y., Shen, Y., Pleasance, E., Kasaian, K., Leelakumari, S., Jones, M. R., Bose, P., Ch’ng, C., Reisle, C., Eirew, P. D., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-1941 · Cited by 179
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumors
Anderson, N. D., de Borja, R., Young, M. D., Fuligni, F., Rosic, A., Roberts, N. D., Hajjar, S., Layeghifard, M., Novokmet, A., Kowalski, P. E., et al. (2018) · Science · doi:10.1126/science.aam8419 · Cited by 191
Self-citationChen, H., Chong, W., Wu, Q., Yao, Y., Mao, M., & Wang, X. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01113 · Cited by 181
Sokol, E. S., Pavlick, D. C., Khiabanian, H., Frampton, G. M., Ross, J. S., Gregg, J. P., Lara, P. N., Oesterreich, S., Agarwal, N., Necchi, A., et al. (2020) · JCO Precision Oncology · doi:10.1200/po.19.00345 · Cited by 182
Luo, W., Wang, J., Xu, W., Ma, C., Wan, F., Huang, Y., Yao, M., Zhang, H., Qu, Y., Ye, D., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04296-1 · Cited by 182
Sosinsky, A., Ambrose, J. C., Cross, W. C. H., Turnbull, C., Henderson, S. J., Jones, J. L., Hamblin, A. D., Arumugam, P., Chan, G. C., Chubb, D., et al. (2024) · Nature Medicine · doi:10.1038/s41591-023-02682-0 · Cited by 193
Herpers, B., Eppink, B., James, M. I., Cortina, C., Cañellas-Socias, A., Boj, S. F., Hernando-Momblona, X., Glodzik, D., Roovers, R. C., van de Wetering, M., et al. (2022) · Nature Cancer · doi:10.1038/s43018-022-00359-0 · Cited by 178
Self-citationKanu, N., Gronroos, E. C., Martinez, P., Burrell, R. A., Goh, X. Y., Bártková, J., Maya‐Mendoza, A., Mistrík, M., Rowan, A., Patel, H., et al. (2015) · Oncogene · doi:10.1038/onc.2015.24 · Cited by 189
Self-citationPan-cancer patterns of DNA methylation
Witte, T., Plass, C., & Gerhäuser, C. (2014) · Genome Medicine · doi:10.1186/s13073-014-0066-6 · Cited by 182
A mutational signature in gastric cancer suggests therapeutic strategies
Alexandrov, L. B., Nik‐Zainal, S., Siu, H. C., Leung, S. Y., & Stratton, M. R. (2015) · Nature Communications · doi:10.1038/ncomms9683 · Cited by 178
Self-citationThe genetics of nodal marginal zone lymphoma
Spina, V., Khiabanian, H., Messina, M., Monti, S. M., Cascione, L., Bruscaggin, A., Spaccarotella, E., Holmes, A. B., Arcaini, L., Lucioni, M., et al. (2016) · Blood · doi:10.1182/blood-2016-02-696757 · Cited by 181
Haradhvala, N. J., Kim, J., Maruvka, Y. E., Polak, P. P., Rosebrock, D., Livitz, D. G., Hess, J. M., Leshchiner, I., Kamburov, A., Mouw, K. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-04002-4 · Cited by 181
Next generation sequencing‐based gene panel tests for the management of solid tumors
Nagahashi, M., Shimada, Y., Ichikawa, H., Kameyama, H., Takabe, K., Okuda, S., & Wakai, T. (2018) · Cancer Science · doi:10.1111/cas.13837 · Cited by 183
Rokita, J. L., Rathi, K. S., Cardenas, M., Upton, K. A., Jayaseelan, J. C., Cross, K. L., Pfeil, J., Egolf, L. E., Way, G. P., Farrel, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.071 · Cited by 185
The landscape of gene mutations in cirrhosis and hepatocellular carcinoma
Müller, M., Bird, T. G., & Nault, J. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2020.01.019 · Cited by 182
Dodagatta-Marri, E., Meyer, D. S., Reeves, M. Q., Paniagua, R., To, M. D., Binnewies, M., Broz, M. L., Mori, H., Wu, D., Adoumie, M., et al. (2019) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0493-9 · Cited by 177
van de Ven, K., & Borst, J. G. (2015) · Immunotherapy · doi:10.2217/imt.15.32 · Cited by 184
Genomic Approaches to Understanding Response and Resistance to Immunotherapy
Braun, D. A., Burke, K. P., & Allen, E. M. V. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0066 · Cited by 178
Fantini, D., Glaser, A. P., Rimar, K. J., Wang, Y., Schipma, M. J., Varghese, N., RADEMAKER, A. W., Behdad, A., Yellapa, A., Yu, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0099-6 · Cited by 179
Tobacco Smoking-Associated Alterations in the Immune Microenvironment of Squamous Cell Carcinomas
Desrichard, A., Kuo, F., Chowell, D., Lee, K.-W., Riaz, N., Wong, R. J., Chan, T. A.-T., & Morris, L. G. T. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy060 · Cited by 178
Wu, V. H., Yeerna, H., Nohata, N., Chiou, J., Harismendy, O., Raimondi, F., Inoue, A., Russell, R. B., Tamayo, P., & Gutkind, J. S. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.rev119.005601 · Cited by 185
Integrated genetic and epigenetic analysis defines novel molecular subgroups in rhabdomyosarcoma
Seki, M., Nishimura, R., Yoshida, K., Shimamura, T., Shiraishi, Y., Sato, Y., Kato, M., Chiba, K., Tanaka, H., Hoshino, N., et al. (2015) · Nature Communications · doi:10.1038/ncomms8557 · Cited by 182
The role of neoantigens in response to immune checkpoint blockade
Riaz, N., Morris, L. G. T., Havel, J. J., Makarov, V., Desrichard, A., & Chan, T. A.-T. (2016) · International Immunology · doi:10.1093/intimm/dxw019 · Cited by 178
Comprehensive Genetic Landscape of Uveal Melanoma by Whole-Genome Sequencing
Royer‐Bertrand, B., Torsello, M., Rimoldi, D., Zaoui, I. E., Cisarova, K. V., Gobert, R. P., Raynaud, F., Zografos, L., Schalenbourg, A., Speiser, D. E., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.09.008 · Cited by 181
Niu, L., Chu, L. Y., Burton, S. A., Hansen, K. J., & Panyam, J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.12.026 · Cited by 177
Taglialatela, A., Leuzzi, G., Sannino, V., Cuella-Martin, R., Huang, J., Wu-Baer, F., Baer, R. J., Costanzo, V., & Ciccia, A. (2021) · Molecular Cell · doi:10.1016/j.molcel.2021.08.016 · Cited by 183
Zheng, S., Wang, W., Shen, L., Yao, Y., Xia, W., & Ni, C. (2024) · Experimental Hematology and Oncology · doi:10.1186/s40164-024-00543-1 · Cited by 200
SF3B1 mutations constitute a novel therapeutic target in breast cancer
Maguire, S. L., Leonidou, A., Wai, P. T., Marchiò, C., Ng, C. K. Y., Sapino, A., Vincent‐Salomon, A., Reis-Filho, J. S., Weigelt, B., & Natrajan, R. (2014) · The Journal of Pathology · doi:10.1002/path.4483 · Cited by 178
Self-citationMGUS to myeloma: a mysterious gammopathy of underexplored significance
Dhodapkar, M. V. (2016) · Blood · doi:10.1182/blood-2016-09-692954 · Cited by 179
Tumour mutational burden: clinical utility, challenges and emerging improvements
Budczies, J., Kazdal, D. N., Menzel, M., Beck, S., Kluck, K., Altbürger, C., Schwab, C., Allgäuer, M., Ahadova, A., Kloor, M., et al. (2024) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-024-00932-9 · Cited by 187
The driver landscape of sporadic chordoma
Tarpey, P. S., Behjati, S., Young, M. D., Martincorena, I., Alexandrov, L. B., Farndon, S. J., Guzzo, C., Hardy, C. W., Latimer, C., Butler, A. P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01026-0 · Cited by 174
Self-citationClonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking
Dawoud, A. A. Z., Tapper, W., & Cross, N. C. P. (2020) · Leukemia · doi:10.1038/s41375-020-0896-8 · Cited by 180
Increased somatic mutation burdens in normal human cells due to defective DNA polymerases
Robinson, P. S., Coorens, T. H. H., Palles, C., Mitchell, E., Abascal, F., Olafsson, S., Lee, B. C. H., Lawson, A. R. J., Lee-Six, H., Moore, L., et al. (2021) · Nature Genetics · doi:10.1038/s41588-021-00930-y · Cited by 173
Self-citationNahar, R., Zhai, W., Zhang, T., Takano, A., Khng, A. J., Lee, Y. Y., Liu, X., Lim, C. H., Koh, T. P. T., Aung, Z. W., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02584-z · Cited by 173
Mutational landscape of gastric adenocarcinoma in Chinese: Implications for prognosis and therapy
Chen, K., Yang, D., Li, X., Sun, B., Song, F., Cao, W., Brat, D. J., Gao, Z., Li, H., Liang, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422640112 · Cited by 174
The genomic landscape of cutaneous melanoma
Zhang, T., Dutton‐Regester, K., Brown, K. M., & Hayward, N. K. (2016) · Pigment Cell & Melanoma Research · doi:10.1111/pcmr.12459 · Cited by 182
Rapid evolution of the human mutation spectrum
Harris, K., & Pritchard, J. K. (2017) · eLife · doi:10.7554/elife.24284 · Cited by 179
An evolutionary case for functional gene body methylation in plants and animals
Zilberman, D. (2017) · Genome biology · doi:10.1186/s13059-017-1230-2 · Cited by 173
Tumor mutation burden: from comprehensive mutational screening to the clinic
Galuppini, F., Pozzo, C. A. D., Deckert, J., Loupakis, F., Fassan, M., & Baffa, R. (2019) · Cancer Cell International · doi:10.1186/s12935-019-0929-4 · Cited by 177
Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4
Wang, Z., Wu, V. H., Allevato, M. M., Gilardi, M., He, Y., Callejas‐Valera, J. L., Vitale-Cross, L. A., Martı́n, D., Amornphimoltham, P., Mcdermott, J., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-13471-0 · Cited by 177
Self-citationBoot, A., Huang, M. N., Ng, A. W. T., Ho, S.-C., Lim, J. Q., Kawakami, Y., Chayama, K., Teh, B. T., Nakagawa, H., & Rozen, S. (2018) · Genome Research · doi:10.1101/gr.230219.117 · Cited by 173
Heßmann, E., Schneider, G., Ellenrieder, V., & Siveke, J. T. (2015) · Oncogene · doi:10.1038/onc.2015.216 · Cited by 178
Differences between germline genomes of monozygotic twins
Jónsson, H., Magnúsdóttir, E., Eggertsson, H. P., Stefánsson, Ó. A., Arnadottir, G. A., Eiríksson, Ö., Zink, F., Helgason, E. A., Jónsdóttir, I., Gylfason, A., et al. (2021) · Nature Genetics · doi:10.1038/s41588-020-00755-1 · Cited by 172
Mismatch repair deficiency is not sufficient to elicit tumor immunogenicity
Westcott, P. M. K., Muyas, F., Hauck, H., Smith, O. C. G., Sacks, N. J., Ely, Z. A., Jaeger, A. M., Rideout, W. M., Zhang, D., Bhutkar, A. J., et al. (2023) · Nature Genetics · doi:10.1038/s41588-023-01499-4 · Cited by 179
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer HeterogeneityPreprint
Martin, J. D., Fukumura, D., Duda, D. G., Boucher, Y., & Jain, R. K. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a027094 · Cited by 179
Mutational Signature Analysis Reveals NTHL1 Deficiency to Cause a Multi-tumor Phenotype
Grolleman, J. E., de Voer, R. M., Elsayed, F. A., Nielsen, M., Weren, R. D. A., Palles, C., Ligtenberg, M. J. L., Vos, J. R., ten Broeke, S. W., de Miranda, N. F. C. C., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2018.12.011 · Cited by 175
Genetic determinants of cellular addiction to DNA polymerase theta
Feng, W., Simpson, D. A., Carvajal-Garcia, J., Price, B. A., Kumar, R. J., Mose, L. E., Wood, R. D., Rashid, N. U., Purvis, J. E., Parker, J. S., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-12234-1 · Cited by 171
Seplyarskiy, V. B., Soldatov, R., Popadin, K. Y., Antonarakis, S. E., Bazykin, G. A., & Nikolaev, S. I. (2016) · Genome Research · doi:10.1101/gr.197046.115 · Cited by 175
Metadata
- Authors
- Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., Bignell, G. R., Bolli, N., Borg, A., Børresen-Dale, A.-L., Boyault, S., Burkhardt, B., Butler, A. P., Caldas, C., Davies, H. R., Desmedt, C., Eils, R., Eyfjörd, J. E., Foekens, J. A., Greaves, M., Hosoda, F., Hutter, B., Ilicic, T., Imbeaud, S., Imielinski, M., Jäger, N., Jones, D. T. W., Jones, D., Knappskog, S., Kool, M., Lakhani, S. R., López-Otín, C., Martin, S., Munshi, N. C., Nakamura, H., Northcott, P. A., Pajic, M., Papaemmanuil, E., Paradiso, A., Pearson, J. V., Puente, X. S., Raine, K., Ramakrishna, M., Richardson, A. L., Richter, J., Rosenstiel, P., Schlesner, M., Schumacher, T. N., Span, P. N., Teague, J. W., Totoki, Y., Tutt, A. N. J., Valdés-Mas, R., van Buuren, M. M., van ’t Veer, L., Vincent-Salomon, A., Waddell, N., Yates, L. R., Zucman-Rossi, J., Andrew Futreal, P., McDermott, U., Lichter, P., Meyerson, M., Grimmond, S. M., Siebert, R., Campo, E., Shibata, T., Pfister, S. M., Campbell, P. J., & Stratton, M. R.
- Affiliations
- Wellcome Sanger Institute (GB)
- BC Cancer Agency (CA)
- University of Cambridge (GB)
- Garvan Institute of Medical Research (AU)
- Lund University (SE)
- Oslo University Hospital (NO)
- Justus-Liebig-Universität Gießen (DE)
- Université Libre de Bruxelles (BE)
- German Cancer Research Center (DE)
- Erasmus MC Cancer Institute (NL)
- Inserm (FR)
- Broad Institute (US)
- The University of Queensland (AU)
- Universidad de Oviedo (ES)
- Harvard University (US)
- National Cancer Center Research Institute (JP)
- University of Glasgow (GB)
- Brigham and Women's Hospital (US)
- The Netherlands Cancer Institute (NL)
- Radboud University Medical Center (NL)
- King's College London (GB)
- Christian-Albrechts-Universität zu Kiel (DE)
- Corresponding author
- Stratton, Michael R.
- ORCID
- Alexandrov, Ludmil B.
- Wedge, David C.
- Aparicio, Samuel A. J. R.
- Behjati, Sam
- Biankin, Andrew V.
- Bolli, Niccolò
- Boyault, Sandrine
- Burkhardt, Birgit
- Caldas, Carlos
- Davies, Helen R.
- Desmedt, Christine
- Eils, Roland
- Hutter, Barbara
- Imbeaud, Sandrine
- Imielinski, Marcin
- Jäger, Natalie
- Knappskog, Stian
- Kool, Marcel
- Lakhani, Sunil R.
- Martin, Sancha
- Munshi, Nikhil C.
- Nakamura, Hiromi
- Northcott, Paul A.
- Pajic, Marina
- Papaemmanuil, Elli
- Paradiso, Angelo
- Pearson, John V.
- Raine, Keiran
- Ramakrishna, Manasa
- Richardson, Andrea L.
- Richter, Julia
- Rosenstiel, Philip
- Schlesner, Matthias
- Schumacher, Ton N.
- Span, Paul N.
- Teague, Jon W.
- Totoki, Yasushi
- Tutt, Andrew N. J.
- Waddell, Nicola
- Yates, Lucy R.
- McDermott, Ultan
- Meyerson, Matthew
- Grimmond, Sean M.
- Siebert, Reiner
- Shibata, Tatsuhiro
- Pfister, Stefan M.
- Campbell, Peter J.
- Stratton, Michael R.
- Venue
- Nature
- Published
- 2013-08-14
- Volume
- 500
- Issue
- 7463
- Pages
- 415-421
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC3776390
- OpenAlex
- W2152061559
- Cited by
- 9,660
- References
- 67
- Citations by year
- 2026: 384 · 2025: 552 · 2024: 643 · 2023: 854 · 2022: 921 · 2021: 1119 · 2020: 1130 · 2019: 939 · 2018: 873 · 2017: 815 · 2016: 660 · 2015: 421 · 2014: 286 · 2013: 45
- FWCI
- 165.61
- Type
- journal article
- Language
- en
- Update notices
- erratum (2013-10-09)
- Open access
- bronze
- doi.org
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
- HAL (submittedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Consultation of the Doctoral Thesis Database (TESEO) (Ministerio de Educación, Cultura y Deporte) (submittedVersion, cc-by-nc-nd)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- OPUS (Augsburg University) (submittedVersion)
- Apollo (University of Cambridge) (submittedVersion)
- Apollo
- Funders
- Deutsches Krebsforschungszentrum (69120)
- Wellcome Trust (088340, 093867, 098051)
- Broad Institute
- Canada's Michael Smith Genome Sciences Centre
- Cancer Research UK
- University of Glasgow
- Agence Nationale de la Recherche (ANR-10-LABX-0015)
- Institut National de la Santé et de la Recherche Médicale
- University of New South Wales
- Lunds Universitet
- Universitetet i Oslo
- Háskóli Íslands
- Universitat de Barcelona
- BC Cancer Agency
- Labex Immuno-Oncology
- Medisinske fakultet, Universitetet i Oslo
- Cancer Research UK Cambridge Institute, University of Cambridge
- National Cancer Institute (T32CA009216)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- mutational signatures, somatic mutations, cancer genome, APOBEC cytidine deaminases, kataegis, hypermutation, patient age, cancer etiology, cancer types
- MeSH terms
- Aging, Algorithms, Cell Transformation, Neoplastic, Cytidine Deaminase, DNA, DNA Mutational Analysis, Humans, Models, Genetic, Mutagens, Mutation, Neoplasms, Organ Specificity, Transcription, Genetic, Reproducibility of Results, Mutagenesis, Insertional, Mutagenesis, Sequence Deletion
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
